ANORO ELLIPTA 62.5-25 MCG INH

umeclidinium bromide and vilanterol trifenatate
$7.8122per EA

Strength

62.5; 25 ug/1; ug/1

NDC

00173086910

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA203975

On Market Since

1/31/2014

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.1%

3Y

+5.9%

5Y

+12.5%

All

+75.5%